A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
Clinical trial NCT04498169 · COMPLETED
Trial details
- NCT number
- NCT04498169
- Sponsor
- Aerie Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2021-08-11
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.